Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag + Dexamethasone in Newly Diagnosed ITP
NCT04812483Phase 2Completed
- Sponsor
- University Children's Hospital Basel
- Start
- Sep 2022
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eltrombopag in primary immune thrombocytopenia (ITP), sponsored by University Children's Hospital Basel. Started Sep 2022; status: completed.
02
Drugs
eltrombopag
03
Conditions
primary immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT04812483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04812483.